Trial Outcomes & Findings for Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families (NCT NCT03256227)
NCT ID: NCT03256227
Last Updated: 2024-06-14
Results Overview
Number of treatment sessions attended by the participant
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
128 participants
Primary outcome timeframe
16 weeks
Results posted on
2024-06-14
Participant Flow
Participant milestones
| Measure |
Family Supported Prolonged Exposure
The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
Family Supported Prolonged Exposure: The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
|
Standard Prolonged Exposure
Standard Prolonged Exposure for PTSD as delivered in routine VA care.
Standard Prolonged Exposure: Standard Prolonged Exposure for PTSD as delivered in routine VA care.
|
|---|---|---|
|
Overall Study
STARTED
|
64
|
64
|
|
Overall Study
COMPLETED
|
36
|
25
|
|
Overall Study
NOT COMPLETED
|
28
|
39
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families
Baseline characteristics by cohort
| Measure |
Family Supported Prolonged Exposure
n=64 Participants
The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
Family Supported Prolonged Exposure: The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
|
Standard Prolonged Exposure
n=64 Participants
Standard Prolonged Exposure for PTSD as delivered in routine VA care.
Standard Prolonged Exposure: Standard Prolonged Exposure for PTSD as delivered in routine VA care.
|
Total
n=128 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
49.30 years
STANDARD_DEVIATION 14.70 • n=5 Participants
|
51.23 years
STANDARD_DEVIATION 15.04 • n=7 Participants
|
50.38 years
STANDARD_DEVIATION 14.81 • n=5 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
50 Participants
n=5 Participants
|
53 Participants
n=7 Participants
|
103 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Black
|
14 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic/Latino
|
1 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · White
|
41 Participants
n=5 Participants
|
36 Participants
n=7 Participants
|
77 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Multiracial
|
4 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Unknown
|
4 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Lives with Significant Other
|
48 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
88 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 16 weeksNumber of treatment sessions attended by the participant
Outcome measures
| Measure |
Family Supported Prolonged Exposure
n=64 Participants
The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
Family Supported Prolonged Exposure: The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
|
Standard Prolonged Exposure
n=64 Participants
Standard Prolonged Exposure for PTSD as delivered in routine VA care.
Standard Prolonged Exposure: Standard Prolonged Exposure for PTSD as delivered in routine VA care.
|
|---|---|---|
|
Session Attendance
|
6.77 sessions
Standard Deviation 3.99
|
5.56 sessions
Standard Deviation 4.16
|
SECONDARY outcome
Timeframe: 16 weeksPopulation: Veterans who completed PCL5 measure at post treatment
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. Range of scale is 0-80 and can be obtained by summing the scores for each of the 20 items. Higher scores indicate higher PTSD symptom levels.
Outcome measures
| Measure |
Family Supported Prolonged Exposure
n=62 Participants
The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
Family Supported Prolonged Exposure: The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
|
Standard Prolonged Exposure
n=62 Participants
Standard Prolonged Exposure for PTSD as delivered in routine VA care.
Standard Prolonged Exposure: Standard Prolonged Exposure for PTSD as delivered in routine VA care.
|
|---|---|---|
|
PTSD Checklist for DSM-5 (PCL-5)
|
51.56 score on a scale
Standard Deviation 12.60
|
53.79 score on a scale
Standard Deviation 12.54
|
Adverse Events
Family Supported Prolonged Exposure
Serious events: 2 serious events
Other events: 17 other events
Deaths: 0 deaths
Standard Prolonged Exposure
Serious events: 2 serious events
Other events: 20 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Family Supported Prolonged Exposure
n=64 participants at risk
The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
Family Supported Prolonged Exposure: The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
|
Standard Prolonged Exposure
n=64 participants at risk
Standard Prolonged Exposure for PTSD as delivered in routine VA care.
Standard Prolonged Exposure: Standard Prolonged Exposure for PTSD as delivered in routine VA care.
|
|---|---|---|
|
Psychiatric disorders
Severe Suicidal ideation
|
3.1%
2/64 • Number of events 2 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
1.6%
1/64 • Number of events 1 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
|
Psychiatric disorders
Psychological decompisation
|
0.00%
0/64 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
1.6%
1/64 • Number of events 1 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
Other adverse events
| Measure |
Family Supported Prolonged Exposure
n=64 participants at risk
The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
Family Supported Prolonged Exposure: The investigators propose to bring a family member into early educational sessions of PE, one of the most researched and efficacious treatments for PTSD, to increase family support for PE adherence. Strategies for how to engage with families are drawn from existing evidence-based approaches, including Motivational Interviewing and Behavioral Couples Therapy.
|
Standard Prolonged Exposure
n=64 participants at risk
Standard Prolonged Exposure for PTSD as delivered in routine VA care.
Standard Prolonged Exposure: Standard Prolonged Exposure for PTSD as delivered in routine VA care.
|
|---|---|---|
|
General disorders
ER visit
|
17.2%
11/64 • Number of events 24 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
21.9%
14/64 • Number of events 18 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
|
General disorders
Hospitalization
|
12.5%
8/64 • Number of events 14 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
9.4%
6/64 • Number of events 9 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
|
Psychiatric disorders
Mild Suicidal ideation
|
0.00%
0/64 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
3.1%
2/64 • Number of events 2 • Treatment initiation through 3 month follow-up, up to 40 weeks.
This is a minimal risk study, so likelihood of mortality is zero.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place